Prevalence, Characteristics, Management, and Outcomes of Difficult-to-treat Inflammatory Bowel Disease

RecruitingOBSERVATIONAL

Enrollment

972

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions

Assessment of the Criteria and Risk Factors for DTT-IBD

Interventions

OTHER

prevalence of difficult-to-treat IBD

To assess the prevalence and risk factors of difficult-to-treat IBD patients

Trial Locations (1)

RECRUITING

IRCCS San Raffaele, Milan

All Listed Sponsors

lead

IRCCS Ospedale San Raffaele

OTHER